fingolimod hydrochloride has been researched along with formaldehyde in 1 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (formaldehyde) | Trials (formaldehyde) | Recent Studies (post-2010) (formaldehyde) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 22,546 | 243 | 5,887 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, DS; Cho, YJ; Choi, CH; Choi, JJ; Kim, BG; Kim, HS; Kim, TJ; Lee, JW; Lee, YY; Ryu, JY; Song, SY; Yoon, G | 1 |
1 other study(ies) available for fingolimod hydrochloride and formaldehyde
| Article | Year |
|---|---|
Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer.
Topics: Adult; Animals; Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Cell Survival; Disease Progression; Disease-Free Survival; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Fingolimod Hydrochloride; Formaldehyde; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Immunohistochemistry; Lymphatic Metastasis; Mice; Mice, Inbred BALB C; Middle Aged; Neoplasm Transplantation; Paraffin Embedding; Phosphotransferases (Alcohol Group Acceptor); Prognosis; Thiazoles; Uterine Cervical Neoplasms | 2015 |